Owner Perlan Therapeutics, Inc.

Inventors Fang, Fang; Luo, Guang-Xiang; Kohlstaedt, Lori Allison; Charles, Catherine Helen

Agent Shelston IP

Pub. Number AU-A-2012203365

Parent 2008258214

Filing date 7 June 2012

Wipo publication date 28 June 2012

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/06 Drugs for disorders of the respiratory system

A61P 31/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/06 Antiparasitic agents

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/02 Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies